We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information to raise awareness with commissioners and providers of the community pharmacy offer for sexual health, reproductive health and HIV services.
Interventions that can be made by pharmacy teams, to improve quality of life for older people.
Information for pharmaceutical wholesalers explaining the main changes the Windsor Framework introduces to the packaging for all medicines licensed in the UK, effective from 1 January 2025.
Canada and UK Trade Continuity Agreement enters into force
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system.
Collecting and acting on information on any adverse effects of electronic cigarette devices and refill containers on human health.
Which submission type to select when submitting a notification of intent to market e-cigarette and vape products in Northern Ireland.
The types of emissions a manufacturer or importer of e-cigarettes should notify us about.
How to test and report levels of nicotine uptake when submitting a notification of intent to market e-cigarette and vape products.
How the ‘Written Confirmation’ process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
Information for patients who have been prescribed Paxlovid (nirmatrelvir 150mg and ritonavir 100mg) film-coated tablets COVID-19 antiviral medication.
Deficiencies in Omega’s pharmacovigilance system are not thought to affect the safety of the products that they market.
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
Poster with advice for healthcare professionals on how to carry out point of care testing safely and correctly.
This guidance sets out the clinical requirements based on the consensus of what is ‘minimally acceptable’ performance in the opinion of the anaesthesia and intensive care medicine professionals and medical device regulators.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Applying for market authorisation for plasma master files (PMFs) and vaccine antigen master files (VAMFs).
VDEC provides a number of services for vaccines post-licensure
Guidance for manufacturers on reporting adverse incidents involving breast implants under the vigilance system.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).